Evidence map›Paper›PMID 41768875›Full record

ArticleMolecular syndromology2026

Different Diagnoses, Common Ancestry: 22q11.2 Deletion Syndrome and Wiskott-Aldrich Syndrome in the Same Family.

Anastasia Bobreshova, Irina Efimova, Anna Mukhina, Daria Bogdanova, Anna Ogneva, Daria Yukhacheva, Zhanna Markova, Dmitry Pershin, Yulia Rodina, Natalya Balinova and 13 more

Abstract readCase Reports
In one paragraph

Article in Molecular syndromology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Anastasia BobreshovaResearch Centre for Medical Genetics, Moscow, Russia.
Irina EfimovaResearch Centre for Medical Genetics, Moscow, Russia.
Anna MukhinaResearch Centre for Medical Genetics, Moscow, Russia.
Daria BogdanovaDmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
Anna OgnevaDmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
Daria YukhachevaDmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
Zhanna MarkovaResearch Centre for Medical Genetics, Moscow, Russia.
Dmitry PershinDmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
Yulia RodinaDmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
Natalya BalinovaResearch Centre for Medical Genetics, Moscow, Russia.
Elena RaykinaDmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
Daria ZhavoronokKrasnoyarsk Regional Clinical Center for Maternity and Childhood Protection, Krasnoyarsk, Russia.
Gulnara SeitovaTomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia.
Dmitrii OrlovTomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia.
Gleb DrozdovTomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia.
Irina SermyaginaResearch Centre for Medical Genetics, Moscow, Russia.
Rena ZinchenkoResearch Centre for Medical Genetics, Moscow, Russia.
Nadezda ShilovaResearch Centre for Medical Genetics, Moscow, Russia.
Alexander PolyakovResearch Centre for Medical Genetics, Moscow, Russia.
Sergey VoroninResearch Centre for Medical Genetics, Moscow, Russia.
Anna ShcherbinaDmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
Sergey KutsevResearch Centre for Medical Genetics, Moscow, Russia.
Andrey MarakhonovResearch Centre for Medical Genetics, Moscow, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Newborn screening program enable pre-symptomatic detection patients with severe forms of T and B cell immunodeficiency. Despite the high prevalence of 22q11.2 deletion syndrome, only 1 in 10 patients develop lymphopenia that can be detected by newborn screening program. This report presents a unique familial case of 22q11.2 deletion syndrome and Wiskott-Aldrich syndrome, highlighting the importance genetic counseling and a detailed analysis of the family history. Case Presentation: The article presents a case of the two rare genetic diseases in patients from the same family: 22q11.2 deletion syndrome in one and Wiskott-Aldrich syndrome in the other. Both diseases belong to the group of combined immunodeficiencies with syndromic features and are potentially life-threatening conditions requiring follow-up by a wide range of specialists: immunologists, geneticists, cardiologists, endocrinologists, and medical psychologists. Conclusion: Our work aimed to describe the clinical manifestations, genetic characteristics, and diagnosis of these disorders. It is worth emphasizing that the timely diagnosis of not only 22q11.2 deletion syndrome but also other primary immunodeficiencies in the Russian Federation became possible due to the introduction of extended neonatal screening into widespread practice. For such patients, comprehensive early interventional treatment and follow-up by a wide range of specialists is important to improve prognosis and quality of life.

Indexed as

22q11.2 deletion syndromeDiGeorge syndromeNewborn screeningT-cell receptor excision circles/kappa-deleting recombination excision circlesWiskott-Aldrich syndrome

Identifiers

PMID41768875
PMCPMC12948402

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.